TrialTrials2022

SOX combined with intraperitoneal perfusion of docetaxel compared with DOS regimen in the first-line therapy for advanced gastric cancer with malignant ascites: a prospective observation.

Yehong Bin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.